Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
C DIFF PROTEASE
Document Type and Number:
WIPO Patent Application WO/2014/193237
Kind Code:
A3
Abstract:
The invention relates to a peptide comprising the amino acid sequence A/P- A/P-V/P/I/C/T-P as a substrate for the protease CD2830 of Clostridium difficile. The invention further relates to kit or device comprising the peptide for determining the presence of Clostridium difficile in a sample and for identifying an agent that is capable of modulating protease activity of CD2830. The invention further relates to a composition, preferably a pharmaceutical composition, comprising an inhibitor of the protease activity of CD2830.

Inventors:
VAN LEEUWEN HANS CHRISTIAAN (NL)
HENSBERGEN PAUL JACOB (NL)
DRIJFHOUT JAN WOUTER (NL)
KUIJPER EDUARD (NL)
CORVER JEROEN (NL)
Application Number:
PCT/NL2014/050349
Publication Date:
March 19, 2015
Filing Date:
May 30, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ACADEMISCH ZIEKENHUIS LEIDEN (NL)
International Classes:
C07K5/087; C07K5/107
Domestic Patent References:
WO2009010765A22009-01-22
Foreign References:
US20060121544A12006-06-08
US20100291100A12010-11-18
Other References:
M. VIDAL ET AL: "Design of Peptoid Analogue Dimers and Measure of Their Affinity for Grb2 SH3 Domains +", BIOCHEMISTRY, vol. 43, no. 23, 1 June 2004 (2004-06-01), pages 7336 - 7344, XP055087222, ISSN: 0006-2960, DOI: 10.1021/bi030252n
JACQUOT ET AL: "High affinity Grb2-SH3 domain ligand incorporating Ceta-substituted prolines in a Sos-derived decapeptide", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 15, no. 3, 19 January 2007 (2007-01-19), pages 1439 - 1447, XP005823084, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2006.11.002
Attorney, Agent or Firm:
JANSEN, C.M. (Johan de Wittlaan 7, JR Den Haag, NL)
Download PDF: